Table 2.

Characteristics of individuals with positive SARS-CoV-2 test during Delta and Omicron periods included in SCRI analysis.

	Delta period (n = 56)	Omicron period (n = 211)
Age, years, median (IQR)	72 (67, 75.5)	60 (49, 72)
Sex, n(%)	*
Male		184 (8 7)
Female		27 (1 3)
Race/ethnicity, n(%)	*
Non-Hispanic white		100 (47)
Non-Hispanic black		67 (32)
Hispanic any race		18 (9)
Other/ unknown		26 (12)
Rurality, n(%)
Rural	21 (38)	54 (2 6)
Urban	35 (62)	157 (7 4)
Booster manufacturer, n(%)
Pfizer	31 (55)	79 (37)
Moderna	25 (45)	132 (63)
2-dose primary series manufacturer, n(%)
Pfizer	31 (55)	80 (38)
Moderna	25 (45)	131 (6 2)
Comorbidities1, n(%)
Asthma	*	25 (12)
Cancer	11 (20)	17 (8)
Chronic kidney disease	*	25 (12)
COPD	*	26 (12)
Cardiovascular disease	*	13 (6)
Diabetes, with complications	14 (25)	30 (14)
Diabetes, without complications	22 (39)	61 (29)
Hypertension	39 (70)	121 (57)
Immunocompromised	21 (38)	45 (21)
Obesity	14 (25)	50 (24)

Abbreviations: COPD, chronic obstructive pulmonary disease; IQR, interquartile range.

^*Reporting of number suppressed due to low value because of privacy concerns.

¹See Supplemental Table 1 of Young-Xu et al.[25] for definitions of variables in this table.